跳至主要内容
临床试验/NCT05483075
NCT05483075已完成不适用

An Exploratory Study Evaluating the Feasibility of a Health Care Provider Guided Exercise Intervention Prior to Surgical Resection of Pancreatic Cancer With Biological Correlative Studies

NYU Langone Health2 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2022年11月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
2
主要终点
Number of Intervention Arm Participants in Compliance with HCP Exercise Intervention

研究概览

简要总结

Pilot study evaluating the feasibility of a 2-4 week health care provider guided exercise intervention prior to surgery for pancreatic cancer.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
None

入排标准

年龄范围
18 Years 至 90 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Willingness and ability to participate in the study procedures
  • Pathologically confirmed pancreatic cancer
  • Candidate for neoadjuvant therapy followed by surgical resection with potentially curative intent. Note: There is no limitation on duration of neoadjuvant therapy.
  • Planned to have at least 2 weeks after completing the last neoadjuvant therapy and surgery
  • Over the age of 18
  • Ability to engage in physical activity as determined by physiatrist review after completion of the Physical Activity Readiness questionnaire (PAR-Q) exercise survey and chart review
  • Agree to study blood draws and tissue collection

排除标准

  • Evidence of metastatic disease
  • Inability to complete physical activity due to recent injury or surgery
  • Uncontrolled heart disease limiting physical activity
  • Participation in another interventional trial that excludes participation in this protocol
  • Subjects who anticipate undergoing a procedure during the course of the trial that will render them unable to engage in physical activity for more than 48 hours
  • Pregnant subjects
  • Individuals who lack the capacity to consent

结局指标

主要结局

Number of Intervention Arm Participants in Compliance with HCP Exercise Intervention

时间窗: Up to Week 4

Compliance with HCP exercise intervention is defined as successful completion of at least 150 minutes of weekly moderate-to-intense physical activity over a minimum of 2 weeks for every week of the prescribed intervention (2, 3 or 4 weeks).

次要结局

  • Change in Number of Tumor-Infiltrating CD8-Positive T Cells(Baseline, Final Study Visit (Between Weeks 2-4))
  • Change in Number of Tumor-Infiltrating CD8-Positive T Cells Expressing IL-15Ra(Baseline, Final Study Visit (Between Weeks 2-4))
  • Minutes Spent in Rapid Eye Movement (REM) Sleep(Up to Week 4)
  • Time Spent in Sedentary Behavior(Up to Week 4)
  • Total Physical Activity Energy Expenditure(Up to Week 4)
  • Number of Participants who Experience an Event that Leads to Delay in Surgical Resection(Up to Week 4)
  • Change in Number of Tumor-Infiltrating CD8-Positive T Cells Expressing CD3(Baseline, Final Study Visit (Between Weeks 2-4))
  • Change in Number of Circulating CD8-Positive T Cells Expressing IL-15Ra as Assessed by Flow Cytometry(Baseline, Final Study Visit (Between Weeks 2-4))
  • Time Spent in Moderate-to-Vigorous Physical Activity (MVPA)(Up to Week 4)
  • Average Daily MET Rates(Up to Week 4)
  • Number of Participants who Experience Adverse Events (AEs)(Up to Week 4)
  • Change in Number of Tumor-Infiltrating CD8-Positive T Cells Expressing GZMB(Baseline, Final Study Visit (Between Weeks 2-4))

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Feasibility of a Health Care Provider Guided... | 临床试验